# BPC-157 15mg / TB-500 15mg Blend

> This is the same two-peptide combination as the standard BPC-157/TB-500 Blend, formulated at a higher total peptide mass per vial (15mg of each, 30mg combined) rather than the more common lower-concentration versions. It is generally intended for longer or higher-volume research protocols, such as addressing more severe or chronic injuries, or simply reducing how frequently a new vial must be reconstituted. The underlying evidence base is the same as the standard-concentration blend, preclinical and animal data on each peptide individually, with no controlled studies of the fixed combination. A higher total vial concentration does not necessarily imply a proportionally greater effect at a given per-injection dose, and higher per-injection amounts may carry a greater likelihood of local side effects. It is not approved for human medical use.

- URL: https://www.lifeconverted.com/peptides/bpc157-tb500-15mg-blend
- Also known as: High-Dose BPC/TB Blend, 30mg Recovery Vial
- Primary category: Healing Blends
- Effectiveness rank: #8 in Healing & Recovery; #5 in Healing Blends
- Evidence level: Moderate evidence
- Route: Subcutaneous (Injected subcutaneously the same way as the standard-concentration blend; the higher total vial content is intended to reduce how often a vial needs to be reconstituted over a longer protocol, not to change per-injection technique.)
- Dose range: 0.3-1 mg
- Dose tiers: low 0.3 mg; moderate 0.5 mg; high 1 mg
- Half-life: As with the standard-concentration blend: BPC-157 is reported at roughly 4 hours, while TB-500 is described as persisting for a much longer duration, on the order of days.
- Timing: Morning, or split AM/PM
- Cycle: 4-6 weeks on, 2-4 weeks off (The larger vial size is often used to support multiple sequential cycles, or a single extended cycle, from one reconstitution rather than implying a different cycling schedule.)
- Storage: Refrigerate after reconstitution (2-8°C) and protect from light. Because the vial is drawn from repeatedly over a longer period, strict sterile technique on each draw is important to avoid contamination or degradation.

## Mechanism of action

The proposed mechanisms are identical to the standard-concentration blend: BPC-157 is studied for angiogenic and fibroblast-related effects at sites of tissue damage, and TB-500 is an actin-binding peptide proposed to support migration of repair-related cells to injured tissue. The higher total vial concentration changes how much peptide is available across a longer protocol; it does not change the underlying mechanism or add a new mode of action.

## Reported benefits

- Supports tendon and ligament tissue repair in preclinical research
- Associated with reduced local inflammation
- Convenient for longer or higher-volume recovery protocols
- Reduces reconstitution frequency compared with lower-concentration vials

## Reported side effects

- Mild nausea
- Head rush or lightheadedness
- Injection site redness or irritation, potentially more pronounced at higher per-injection volumes
- Lethargy (more often reported with TB-500)

## Common protocols

- Extended Recovery Protocol
- Chronic Injury Support
- Multi-Cycle Repair Stack

## Stacking notes

Same stacking considerations as the standard-concentration BPC-157/TB-500 Blend; commonly used as the base for extended or higher-severity recovery protocols rather than combined with additional peptides in the same vial.

---

Educational information only, not medical advice. Full disclaimer: https://www.lifeconverted.com/disclaimer